clopidogrel and Sclerosis, Systemic

clopidogrel has been researched along with Sclerosis, Systemic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alexopoulos, D; Andonopoulos, AP; Daoussis, D; Davlouros, P; Filippopoulou, A; Gkizas, V; Ntelis, K	1

Trials

1 trial(s) available for clopidogrel and Sclerosis, Systemic

Article	Year
Clopidogrel treatment may associate with worsening of endothelial function and development of new digital ulcers in patients with systemic sclerosis: results from an open label, proof of concept study. BMC musculoskeletal disorders, 2016, 05-17, Volume: 17 Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Animals; Clopidogrel; Endothelium, Vascular; Female; Fingers; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Proof of Concept Study; Purinergic P2Y Receptor Antagonists; Scleroderma, Systemic; Serotonin; Skin Ulcer; Ticlopidine; Vascular Cell Adhesion Molecule-1	2016

Article

Year

Clopidogrel treatment may associate with worsening of endothelial function and development of new digital ulcers in patients with systemic sclerosis: results from an open label, proof of concept study.

BMC musculoskeletal disorders, 2016, 05-17, Volume: 17

Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Animals; Clopidogrel; Endothelium, Vascular; Female; Fingers; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Proof of Concept Study; Purinergic P2Y Receptor Antagonists; Scleroderma, Systemic; Serotonin; Skin Ulcer; Ticlopidine; Vascular Cell Adhesion Molecule-1

2016